Studies have found ways that people can reduce or prevent weight gain and even continue to lose weight after stopping a GLP-1
By using specific peptides, researchers are learning how to fine-tune the body's response to injury and stress
Others pointed to obesity
Regressive changes of astroglia in white matter lesions in cerebrovascular disease and Alzheimers disease patients
The concomitant improvement in insulin sensitivity and beta-cell function, which were associated with normalization of glucose levels in people with prediabetes, suggests that tirzepatide treatment may delay and potentially halt progression to T2D, by inducing so-called beta-cell rest and ultimately, modifying the natural history of prediabetes/T2D
Clinical evidence from the STEP trials demonstrated that semaglutide reduces appetite, slows stomach emptying, and helps regulate blood sugar, leading to significant sustained weight loss over 68 weeks of treatment